Literature DB >> 26295186

A Generalizable Platform for the Photoactivation of Cell Surface Receptors.

Thinh Nguyen Duc1, Morgan Huse2.   

Abstract

Polarized signal transduction from cell surface receptors plays a central role in the development and homeostasis of multicellular organisms, and it also contributes to cellular dysfunction in many disease states. Understanding the molecular and cellular bases of polarized signaling requires experimental methods that provide precise spatiotemporal control of receptor activation. However, we currently lack strategies for inducing both sustained and spatially constrained signal transduction. In the present study, we combined synthetic and cell biological tools to develop a generalizable photoactivation approach for the stimulation of cell surface receptors. Our system, which is based upon the local decaging of a "universal" peptide ligand, is particularly well suited for the live imaging of single cells. We anticipate that it will greatly facilitate future mechanistic analyses of polarized signal transduction in a variety of cell types.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26295186      PMCID: PMC5015005          DOI: 10.1021/acschembio.5b00372

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  25 in total

1.  Spatial and temporal dynamics of T cell receptor signaling with a photoactivatable agonist.

Authors:  Morgan Huse; Lawrence O Klein; Andrew T Girvin; Joycelyn M Faraj; Qi-Jing Li; Michael S Kuhns; Mark M Davis
Journal:  Immunity       Date:  2007-07-12       Impact factor: 31.745

2.  Temporally precise in vivo control of intracellular signalling.

Authors:  Raag D Airan; Kimberly R Thompson; Lief E Fenno; Hannah Bernstein; Karl Deisseroth
Journal:  Nature       Date:  2009-03-18       Impact factor: 49.962

3.  Spatio-temporally precise activation of engineered receptor tyrosine kinases by light.

Authors:  Michael Grusch; Karin Schelch; Robert Riedler; Eva Reichhart; Christopher Differ; Walter Berger; Álvaro Inglés-Prieto; Harald Janovjak
Journal:  EMBO J       Date:  2014-07-01       Impact factor: 11.598

Review 4.  The epidermal growth factor receptor pathway: a model for targeted therapy.

Authors:  Maurizio Scaltriti; José Baselga
Journal:  Clin Cancer Res       Date:  2006-09-15       Impact factor: 12.531

Review 5.  Erythropoietin, erythropoiesis and beyond.

Authors:  S Chateauvieux; C Grigorakaki; F Morceau; M Dicato; M Diederich
Journal:  Biochem Pharmacol       Date:  2011-07-07       Impact factor: 5.858

6.  The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1.

Authors:  Haihong Zhong; Michael J May; Eijiro Jimi; Sankar Ghosh
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

7.  TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta.

Authors:  Jonathan C Kagan; Tian Su; Tiffany Horng; Amy Chow; Shizuo Akira; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2008-02-24       Impact factor: 25.606

Review 8.  Axon growth and guidance: receptor regulation and signal transduction.

Authors:  Michael O'Donnell; Rebecca K Chance; Greg J Bashaw
Journal:  Annu Rev Neurosci       Date:  2009       Impact factor: 12.449

9.  Optogenetic control of chemokine receptor signal and T-cell migration.

Authors:  Yuexin Xu; Young-Min Hyun; Kihong Lim; Hyunwook Lee; Ryan J Cummings; Scott A Gerber; Seyeon Bae; Thomas Yoonsang Cho; Edith M Lord; Minsoo Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-14       Impact factor: 11.205

10.  A genetically encoded photoactivatable Rac controls the motility of living cells.

Authors:  Yi I Wu; Daniel Frey; Oana I Lungu; Angelika Jaehrig; Ilme Schlichting; Brian Kuhlman; Klaus M Hahn
Journal:  Nature       Date:  2009-08-19       Impact factor: 49.962

View more
  1 in total

1.  Spatial and Temporal Control of T Cell Activation Using a Photoactivatable Agonist.

Authors:  Elisa Sanchez; Morgan Huse
Journal:  J Vis Exp       Date:  2018-04-25       Impact factor: 1.355

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.